November 4, 2017 07:29 PM EDT

Shooting for a new standard on osteoarthritis, Merck KGaA outlines promising data for a potential game-changer

Merck KGaA’s pharma group is taking one more step in a long journey toward rehabbing its rep in the R&D field this weekend. Company execs …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Shoot­ing for a new stan­dard on os­teoarthri­tis, Mer­ck KGaA out­lines promis­ing da­ta for a po­ten­tial game-chang­er